戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (left1)

通し番号をクリックするとPubMedの該当ページを表示します
1                                              scRNA-seq analysis of the organoids revealed enhanced GA
2                                              scRNA-seq data have two unique challenges that can affec
3                                              scRNA-seq may improve our understanding of complicated h
4                                              scRNA-seq of BAL cells from lung transplant recipients i
5                                              scRNA-seq of cancer cells illuminated targetable oncogen
6                                              scRNA-seq revealed that both TREM2 deletion and anti-TRE
7 analyzing a mixture sample sequenced with 13 scRNA-seq protocols.
8          We tested SAME-clustering across 15 scRNA-seq datasets generated by different platforms, wit
9 re, we perform a systematic evaluation of 18 scRNA-seq imputation methods to assess their accuracy an
10 d on canonical correlation analysis of 5,265 scRNA-seq profiles, we identified 18 unique cell populat
11 ticate putative cell types discovered from a scRNA-seq dataset.
12                                         In a scRNA-seq glioblastoma dataset, we discover a recurrent
13                           Here, we present a scRNA-seq platform, named Paired-seq, with high cells/be
14                                Additionally, scRNA-seq datasets often contain technical sources of no
15                                     Although scRNA-seq is now ubiquitously adopted in studies of intr
16 orm and software selection when designing an scRNA-seq study.
17                       As a result, analyzing scRNA-seq data requires extensive considerations of prog
18 logy, and function, we used bulk RNA-seq and scRNA-seq to interrogate the developing human intestine,
19    A method for combined lineage tracing and scRNA-seq reveals the interplay between complementary ge
20          Benchmarking using expert-annotated scRNA-seq datasets shows that our method automatically i
21 mal tissues based on bulk RNA-seq as well as scRNA-seq data.
22 Review, we summarize the currently available scRNA-seq technologies and analytical tools and discuss
23      We demonstrate using publicly available scRNA-seq datasets and simulated expression data that ba
24  proposed method on eight publicly available scRNA-seq datasets with known cell types as well as five
25  is corroborated in other publicly available scRNA-seq datasets.
26                   We found that, on average, scRNA-seq data from only five genes predicted a cell's p
27 ds for integrating the cell clusters between scRNA-seq and scATAC-seq.
28                  When applied to mouse brain scRNA-seq datasets, SCATS identified more differential s
29              Biological features revealed by scRNA-seq were biomarkers of clinical outcomes in indepe
30 curs widely, impacting bulk and single cell (scRNA-seq) data set analysis.
31 ression of key phenotypic features of cells, scRNA-seq platforms are needed that are both high fideli
32 mble clustering is not limited to clustering scRNA-seq data and may be useful to a wide range of clus
33  R-based tool that is scalable to clustering scRNA-seq data with 10 million cells.
34 vised deep embedding algorithm that clusters scRNA-seq data by iteratively optimizing a clustering ob
35                           Lastly, we compare scRNA-seq profiles from pediatric Crohn's disease epithe
36 o account for both dropout rates and complex scRNA-seq data distributions in the same model.
37                                      Current scRNA-seq analysis methods typically overcome dropout by
38 rately or in mixtures, we compared different scRNA-seq platforms and several preprocessing, normaliza
39  contamination levels between four different scRNA-seq protocols.
40 orks equally well on datasets from different scRNA-seq protocols and is scalable to datasets with ove
41 entifies driver regulators from differential scRNA-seq genes and scATAC-seq peaks.
42 aring novel and published data from distinct scRNA-seq modalities that were acquired from the same ti
43                           However, effective scRNA-seq quantification tools tailored for TEs are lack
44                                     Existing scRNA-seq platforms utilize bead-based technologies uniq
45 , including several annotated in an existing scRNA-seq gastrulation atlas, and use this approach to g
46 fore be a useful tool to complement existing scRNA-seq pipelines.
47 ications of BAMM-SC to in-house experimental scRNA-seq datasets using blood, lung and skin cells from
48                                          For scRNA-seq data lacking UMIs, we propose quasi-UMIs: quan
49     We introduce netNMF-sc, an algorithm for scRNA-seq analysis that leverages information across bot
50 ls SCENIC/AUCell and metaVIPER, designed for scRNA-seq.
51 e generative adversarial networks (GANs) for scRNA-seq imputation (scIGANs), which uses generated cel
52    We propose DENDRO, an analysis method for scRNA-seq data that clusters single cells into genetical
53 hoosing dimensionality reduction methods for scRNA-seq data analysis.
54 on clustering and classification methods for scRNA-seq data, in particular, integrated methods, and p
55 ly used dimensionality reduction methods for scRNA-seq studies.
56 -inflated, as a suitable reference model for scRNA-seq analysis.
57 e step of ranking is intuitively natural for scRNA-seq data and provides a non-parametric method for
58 resent scedar, a scalable Python package for scRNA-seq exploratory data analysis.
59                  Many existing pipelines for scRNA-seq data apply pre-processing steps such as normal
60 Ns from bulk samples may not be suitable for scRNA-seq data.
61  implement a heatmap-style visualization for scRNA-seq based on one-dimensional t-SNE for simultaneou
62 ), to impute surface protein abundances from scRNA-seq data by learning from existing single-cell mul
63 r detecting and visualizing dynamic APA from scRNA-seq data.
64 dynamic APA among different cell groups from scRNA-seq data.
65 ecovery of gene expression measurements from scRNA-seq data.
66 ions and inference of clonal membership from scRNA-seq is currently unreliable.
67 vailable for investigating APA profiles from scRNA-seq data.
68    We then present scCC, which map SRTs from scRNA-seq libraries, simultaneously identifying cell typ
69 ) for predicting differentiation states from scRNA-seq data.
70 ypes to human diseases and therapeutics from scRNA-seq profiles are daunting tasks.
71                                 Furthermore, scRNA-seq reveals the same phenomenon after a short in v
72 ndividual, these results could inform future scRNA-seq studies to ensure the most efficient experimen
73     Although the specific steps of any given scRNA-seq analysis might differ depending on the biologi
74                                     However, scRNA-seq data has characteristics such as drop-out even
75 we supplement cell type information of human scRNA-seq data, with mouse.
76 icing) for differential splicing analysis in scRNA-seq, which achieves high sensitivity at low covera
77     A spatial metric for individual cells in scRNA-seq data is first established based on a map conne
78 l similarity estimation, which is crucial in scRNA-seq drop-out imputation but has not been appropria
79                By using variants detected in scRNA-seq reads, it is possible to assign cells to their
80 ion and differential expression detection in scRNA-seq data.
81 ata, and sparse variant alleles expressed in scRNA-seq data.
82 h and cell numbers, two important factors in scRNA-seq, has not been determined for a complex cell po
83 e network structure associated with genes in scRNA-seq data.
84  discrete versus continuous heterogeneity in scRNA-seq data and found that SPNs in the striatum can b
85   Despite the existence of zero inflation in scRNA-seq counts, we recommend the generalized linear mo
86 ies argue that there is no zero inflation in scRNA-seq data.
87 , the unique data characteristics present in scRNA-seq such as sparsity and heterogeneity increase th
88 imate low-dimensional nonlinear structure in scRNA-seq data.
89 annotation of hidden sources of variation in scRNA-seq data.
90  recently for studying 'wanted' variation in scRNA-seq data.
91  Developing a novel strategy for integrating scRNA-seq data with GWAS data, we identified 26, exclusi
92    Overall, DecontX can be incorporated into scRNA-seq workflows to improve downstream analyses.
93 ppear to be a key driver of clonal kinetics, scRNA-seq demonstrates that clones that expand after inf
94   However, because of technical limitations, scRNA-seq data often contain zero counts for many transc
95 ancer dataset and to newly generated matched scRNA-seq and exome-seq data from 32 human dermal fibrob
96                                 SCATS models scRNA-seq data either with or without Unique Molecular I
97                                    Moreover, scRNA-seq dataset characteristics (for example, sample a
98 NA-seq data, it is urgent to develop the new scRNA-seq clustering methods.
99 cal and biological noise found in normalized scRNA-seq data.
100                   The widespread adoption of scRNA-seq has created a need for user-friendly software
101              With the increasing adoption of scRNA-seq, we believe SCATS will be well-suited for vari
102 g exons is essential in splicing analysis of scRNA-seq data as it naturally aggregates spliced reads
103 r dropout events, complicate the analysis of scRNA-seq data using standard methods developed for bulk
104            Pseudotime trajectory analysis of scRNA-seq data was used to predict differentiation of no
105 eukaryotic systems(1-13), the application of scRNA-seq to prokaryotes has been hindered by their extr
106 Our approach for mapping the architecture of scRNA-seq-defined subpopulations can be applied to revea
107 ity and large sample sizes characteristic of scRNA-seq data.
108 ate this by utilizing DR-A for clustering of scRNA-seq data.
109 lations are then determined by clustering of scRNA-seq data.
110                     Through a combination of scRNA-seq, ATAC-seq and genome-scale CRISPR-Cas9 screeni
111         In order to reduce the complexity of scRNA-seq data analysis, we present scedar, a scalable P
112 rtitioning and is an important confounder of scRNA-seq analysis.
113 , and provide a comprehensive description of scRNA-seq data and download URLs.
114 uction and feature gene extraction (EDGE) of scRNA-seq data.
115     An increase in the capture efficiency of scRNA-seq would also be beneficial.
116 lexibility to account for common features of scRNA-seq: high proportions of zero values, increased ce
117 yesian approach for scaling and inference of scRNA-seq counts.
118                We found that the majority of scRNA-seq imputation methods outperformed no imputation
119 or pipeline steps, illustrate the options of scRNA-seq platforms, summarize new knowledge gained from
120      scruff streamlines the preprocessing of scRNA-seq data in a few simple R commands.
121 l transport to recover spatial properties of scRNA-seq data by utilizing spatial measurements of a re
122        Analyzing the high-content readout of scRNA-seq reveals both shared and context-specific trans
123 c learns a low-dimensional representation of scRNA-seq transcript counts using network-regularized no
124 sion reduction tools across a diverse set of scRNA-seq data sets to highlight our model's ability to
125 ing observations and batch effect typical of scRNA-seq datasets make this task particularly challengi
126 RNA sequencing (scRNA-seq), large volumes of scRNA-seq data are being obtained for various processes.
127  of most optimal marker selection methods on scRNA-seq data.
128 d for bulk transcriptomics perform poorly on scRNA-seq data and progress on single cell-specific tech
129 ond-Strand Synthesis"), a massively parallel scRNA-seq protocol that uses a randomly primed second-st
130                                 We performed scRNA-seq analyses on immune and stromal populations fro
131 ning human retinal development, we performed scRNA-seq analysis on 16 time points from developing ret
132                                 We performed scRNA-seq on skin and blood from a patient with refracto
133                                By performing scRNA-seq on peripheral blood mononuclear cells from fou
134 e analysis between Toxoplasma and Plasmodium scRNA-seq results reveals concerted expression of gene s
135 pciSeq), an approach that leverages previous scRNA-seq classification to identify cell types using mu
136 stering or classification methods to process scRNA-seq data is generally difficult.
137 omputational workflow involved in processing scRNA-seq data.
138 seq)-a low-cost, high-throughput prokaryotic scRNA-seq pipeline that overcomes these technical obstac
139 omprehensive benchmarking tests on 17 public scRNA-seq data sets show that SHARP outperforms existing
140                   Using a recently published scRNA-seq study of tissue T cells as an example, we intr
141 -fold more podocytes compared with published scRNA-seq datasets (2.4% versus 0.12%, respectively).
142     As demonstrated using simulated and real scRNA-seq data, the VAM method provides superior classif
143 ene covariance using both simulated and real scRNA-seq data, with increasing advantages at higher dro
144 form benchmark studies on simulated and real scRNA-seq data.
145 f SCATS, we analyzed both simulated and real scRNA-seq datasets and compared with existing methods in
146 ons based on a variety of simulated and real scRNA-seq datasets show that scIGANs is effective for dr
147 ng cell types in multiple simulated and real scRNA-seq datasets.
148  of scDoc using both simulated data and real scRNA-seq studies.
149 roduce different statistics observed in real scRNA-seq data.
150   We complement the simulated data with real scRNA-seq data upon CRISPR-mediated knock-out.
151 inflation in multiple biologically realistic scRNA-seq datasets.
152 omic profiles, and clustering on large-scale scRNA-seq datasets.
153  define cell types from single-cell RNA-seq (scRNA-seq) and single-nucleus ATAC-seq (snATAC-seq) data
154 analysis of RNA-seq and single-cell RNA-seq (scRNA-seq) data from the same lung cell populations indi
155 step in the analysis of single cell RNA-seq (scRNA-seq) data to shed light on tissue complexity inclu
156                      In single-cell RNA-seq (scRNA-seq) experiments, the number of individual cells h
157  linking microscopy and single-cell RNA-seq (scRNA-seq) have limited scalability.
158                         Single cell RNA-seq (scRNA-seq) is a powerful tool to discover cellular heter
159  approach that utilizes single-cell RNA-seq (scRNA-seq) or single-nucleus RNA-seq (snRNA-seq) data to
160                         Single-cell RNA-seq (scRNA-seq) profiles gene expression of individual cells.
161      Recent advances in single-cell RNA-seq (scRNA-seq) revolutionized cell type-specific gene expres
162                   Early single-cell RNA-seq (scRNA-seq) studies suggested that it was unusual to see
163        The emergence of single-cell RNA-seq (scRNA-seq) technology has made it possible to measure ge
164           However, compared to bulk RNA-seq, scRNA-seq data are much noisier due to high technical va
165 before Lgr5, and single-cell RNA sequencing (scRNA-seq) analyses reveal transcriptional paths underly
166              Our single-cell RNA sequencing (scRNA-seq) analysis reveals novel mesenchymal and transi
167 adult SPNs using single-cell RNA sequencing (scRNA-seq) and quantitative RNA in situ hybridization (I
168  Here we applied single-cell RNA sequencing (scRNA-seq) and single-cell assay for transposase-accessi
169  a droplet-based single-cell RNA sequencing (scRNA-seq) approach to systematically classify molecular
170 all intestine by single-cell RNA sequencing (scRNA-seq) at steady state and after induction of a type
171                  Single-cell RNA sequencing (scRNA-seq) can be used to explore cell types, states, an
172                  Single-cell RNA sequencing (scRNA-seq) can characterize cell types and states throug
173 dic protocols in single cell RNA sequencing (scRNA-seq) collect mRNA counts from up to one million in
174      Integrating single-cell RNA sequencing (scRNA-seq) data with genotypes obtained from DNA sequenc
175  cell types from single-cell RNA sequencing (scRNA-seq) data.
176 blicly available single-cell RNA sequencing (scRNA-seq) dataset of melanoma samples of patients subje
177 omparing diverse single-cell RNA sequencing (scRNA-seq) datasets generated by different technologies
178                  Single-cell RNA sequencing (scRNA-seq) deconvolves cell types from gene expression,
179                  Single-cell RNA sequencing (scRNA-seq) enables the systematic identification of cell
180 is, we performed single-cell RNA sequencing (scRNA-seq) from a pool of 2,045 parasites collected from
181 e development of single-cell RNA sequencing (scRNA-seq) has allowed high-resolution analysis of cell-
182                  Single-cell RNA sequencing (scRNA-seq) has become an essential tool for characterizi
183                  Single-cell RNA sequencing (scRNA-seq) has enabled the simultaneous transcriptomic p
184 cerebral cortex, single-cell RNA sequencing (scRNA-seq) has revealed the genome-wide expression patte
185         Although single-cell RNA sequencing (scRNA-seq) has revolutionized studies of transcriptional
186            Using single-cell RNA sequencing (scRNA-seq) in Arabidopsis thaliana tetraploid lines and
187                  Single-cell RNA sequencing (scRNA-seq) is a popular and powerful technology that all
188                  Single-cell RNA sequencing (scRNA-seq) is a powerful approach for reconstructing cel
189                  Single-cell RNA sequencing (scRNA-seq) is a powerful tool for defining cellular dive
190                  Single-cell RNA sequencing (scRNA-seq) is a technology to measure gene expression in
191                  Single-cell RNA sequencing (scRNA-seq) is an emerging technology that can assess the
192            While single cell RNA sequencing (scRNA-seq) is invaluable for studying cell populations,
193                  Single-cell RNA sequencing (scRNA-seq) is the leading technique for characterizing t
194 re we report the single-cell RNA sequencing (scRNA-seq) of ALK3(bright+)-sorted ductal cells, a fract
195 ecipient DNA and single-cell RNA sequencing (scRNA-seq) of five human kidney transplant biopsy cores
196                  Single-cell RNA sequencing (scRNA-seq) of metastatic lung cancer was performed using
197  here we perform single-cell RNA sequencing (scRNA-seq) of peripheral blood mononuclear cells from op
198                  Single-cell RNA sequencing (scRNA-seq) of the tumors identified hypoxic cancer cells
199 ere we performed single-cell RNA sequencing (scRNA-seq) of total 125,674 cells from seven stage-I/II
200 rent methods for single-cell RNA sequencing (scRNA-seq) of yeast cells do not match the throughput an
201 on, we performed single-cell RNA sequencing (scRNA-seq) on biopsies from a patient with cCD and analy
202      Progress in single-cell RNA sequencing (scRNA-seq) provides an opportunity to dissect human dise
203                  Single-cell RNA sequencing (scRNA-seq) provides details for individual cells; howeve
204                  Single-cell RNA sequencing (scRNA-seq) resolves heterogenous cell populations in tis
205                  Single-cell RNA sequencing (scRNA-seq) reveals that ~15% of lung ECs are transcripti
206 monly applied in single cell RNA sequencing (scRNA-seq) studies.
207                  Single-cell RNA sequencing (scRNA-seq) technologies allow researchers to uncover the
208                  Single-cell RNA sequencing (scRNA-seq) technologies enable the study of transcriptio
209 cent progress in single-cell RNA sequencing (scRNA-seq) technologies enables identification of cell-t
210   However, these single-cell RNA sequencing (scRNA-seq) technologies generate an extraordinary amount
211      Advances in single-cell RNA sequencing (scRNA-seq) technologies in the past 10 years have had a
212          We used single-cell RNA sequencing (scRNA-seq) to achieve an unbiased characterization of th
213 ere, we employed single-cell RNA sequencing (scRNA-seq) to examine the immature postnatal thymocyte p
214 te analysis, and single-cell RNA sequencing (scRNA-seq) to profile CD8(+) CAR-T cells from infusion p
215 D-19, we applied single-cell RNA sequencing (scRNA-seq) to profile peripheral blood mononuclear cells
216 al organoids and single-cell RNA sequencing (scRNA-seq) to study the effects of prenatal METH exposur
217                  Single-cell RNA sequencing (scRNA-seq) was performed on airway inflammatory cells is
218 ach by combining single-cell RNA sequencing (scRNA-seq) with Raman optical tweezers (ROT), a label-fr
219     We performed single-cell RNA sequencing (scRNA-seq) with the clinically relevant unilateral ische
220 th the advent of single-cell RNA sequencing (scRNA-seq), it is in principle possible to do such an an
221 ical advances in single-cell RNA sequencing (scRNA-seq), large volumes of scRNA-seq data are being ob
222 ologies, such as single-cell RNA sequencing (scRNA-seq), there is a need for developing novel network
223 the single cell level, using RNA sequencing (scRNA-seq), there is the potential to identify specific
224            Using single-cell RNA sequencing (scRNA-seq), we have identified a population of endotheli
225 e major goals in single cell RNA sequencing (scRNA-seq).
226 e reliability of single cell RNA sequencing (scRNA-seq).
227 as determined by single-cell RNA sequencing (scRNA-seq).
228  used to perform single-cell RNA sequencing (scRNA-seq).
229                  Single-cell RNA-sequencing (scRNA-seq) allows us to dissect transcriptional heteroge
230                  Single-cell RNA-sequencing (scRNA-seq) analysis demonstrated considerable heterogene
231            Using single-cell RNA-sequencing (scRNA-seq) and genetic reporter mice, we identified disc
232 ources involving single-cell RNA-sequencing (scRNA-seq) data are expanding rapidly.
233 ds to deconvolve single-cell RNA-sequencing (scRNA-seq) data are necessary for samples containing a m
234 milarity between single-cell RNA-sequencing (scRNA-seq) data are ubiquitous in bioinformatics, but us
235 cess large-scale single-cell RNA-sequencing (scRNA-seq) data effectively without excessive distortion
236 cently published single-cell RNA-sequencing (scRNA-seq) data from 727 peripheral and nervous system c
237 Normalization of single-cell RNA-sequencing (scRNA-seq) data is a prerequisite to their interpretatio
238 ical analysis of single cell RNA-sequencing (scRNA-seq) data is hindered by high levels of technical
239 iously generated single-cell RNA-sequencing (scRNA-seq) data of gastric corpus epithelium to define t
240  for visualizing single-cell RNA-sequencing (scRNA-seq) data, but it scales poorly to large datasets.
241  as dropouts) in single-cell RNA-sequencing (scRNA-seq) data.
242 imate, and mouse single-cell RNA-sequencing (scRNA-seq) datasets across health and disease to uncover
243                  Single-cell RNA-sequencing (scRNA-seq) enables high-throughput measurement of RNA ex
244                  Single-cell RNA-sequencing (scRNA-seq) enables the characterization of transcriptomi
245 cent advances in single-cell RNA-sequencing (scRNA-seq) facilitate detailed characterization of gene
246                  Single-cell RNA-sequencing (scRNA-seq) has become an important tool to unravel cellu
247 VD by performing single-cell RNA-sequencing (scRNA-seq) in primary AF and NP cells isolated from non-
248  High-throughput single-cell RNA-sequencing (scRNA-seq) methodologies enable characterization of comp
249 Here, we applied single-cell RNA-sequencing (scRNA-seq) on >5,400 Toxoplasma in both tachyzoite and b
250                  Single-cell RNA-sequencing (scRNA-seq) represents a powerful tool for dissecting com
251 d development of single-cell RNA-sequencing (scRNA-seq) technologies has led to the emergence of many
252                  Single-cell RNA-sequencing (scRNA-seq) technology enables studying gene expression p
253 iseases, we used single-cell RNA-sequencing (scRNA-seq) to analyze the transcriptomes of ~85,000 cell
254      Here we use single-cell RNA-sequencing (scRNA-seq) to build a comprehensive cell atlas of the ad
255 -based single cell transcriptome sequencing (scRNA-seq) technology, largely represented by the 10x Ge
256 el DGRN inference method using "time-series" scRNA-seq data.
257 e over several existing methods on simulated scRNA-seq datasets by finding more differentially expres
258                                Specifically, scRNA-seq has facilitated the identification of novel or
259                                          The scRNA-seq, comprehensive, cell-specific profiles provide
260 ited for unsupervised learning tasks for the scRNA-seq data, where labels for cell types are costly a
261 esents a competing imputation method for the scRNA-seq data.
262                                 However, the scRNA-seq data are challenging for traditional methods d
263            Analysis of expressed SNVs in the scRNA-seq data set distinguished recipient versus donor
264 curate low dimensional representation of the scRNA-seq data.
265 ial first step in downstream analysis of the scRNA-seq data.
266                     We hypothesized that the scRNA-seq data of mouse brain tissue can be used to comp
267 ing the genetic variants detected within the scRNA-seq reads.
268                                        These scRNA-seq resources are free of cross-contamination and
269                                         This scRNA-seq atlas will be a valuable resource for dissecti
270          We also apply iDEA to analyze three scRNA-seq data sets, where iDEA achieves up to five-fold
271    The proposed methods are applied on three scRNA-seq datasets.
272  pipelines when dealing with high throughput scRNA-seq data.
273 ligation transcriptomics), a high-throughput scRNA-seq method for Gram-negative and Gram-positive bac
274                                        Thus, scRNA-seq analyses guided successful therapeutic interve
275          We further expanded our analysis to scRNA-seq data from early stages of mouse embryogenesis.
276 urated footprint gene sets can be applied to scRNA-seq data, partially outperforming dedicated single
277 lished for bulk sequencing can be applied to scRNA-seq in a meaningful way.
278           We further applied our approach to scRNA-seq transformed by kNN smoothing and found that ou
279              However, one major challenge to scRNA-seq research is the presence of 'drop-out' events,
280 ically for UMI data to be applied to non-UMI scRNA-seq datasets.
281 multicenter study comparing 13 commonly used scRNA-seq and single-nucleus RNA-seq protocols applied t
282 library construction, the most commonly used scRNA-seq protocol-10x Genomics enables us to improve th
283          To fill this knowledge gap, we used scRNA-seq to profile the placental villous tree, basal p
284 ntal and computational methodology that uses scRNA-seq to characterize dynamic cellular programs and
285                                        Using scRNA-seq profiling and genetic lineage tracing, we show
286                                        Using scRNA-seq to probe unsorted cells from regenerating, sca
287 o resolve isoforms in individual cells using scRNA-seq.
288  tools and discuss the latest findings using scRNA-seq that have substantially improved our knowledge
289 oenvironment at single-cell resolution using scRNA-seq of 59,915 tumor and non-neoplastic cells from
290 possible to study alternative splicing using scRNA-seq.
291 hods by applying it on datasets from various scRNA-seq protocols.
292  developed to process, analyse and visualize scRNA-seq datasets.
293                            Whole genome-wide scRNA-seq, ATAC-seq, and ChIP-seq analyses reveal that A
294  We additionally integrate our analysis with scRNA-seq data to identify orthogonal evidence for trans
295 ly process specific problems associated with scRNA-seq data.
296 at the high rate of dropouts associated with scRNA-seq is a major obstacle to studying alternative sp
297 soform choice and the errors associated with scRNA-seq is required.
298 ntification pipeline that is compatible with scRNA-seq data generated across multiple technology plat
299  Here, we combined fluorescence imaging with scRNA-seq to measure cell cycle phase and gene expressio
300 ures, patient samples, and mouse models with scRNA-seq to elucidate early events occurring with oncog

 
Page Top